Back to Insider Trading View Full Company Profile

ELVN

UNKNOWN

Enliven Therapeutics, Inc.

CIK: 0001672619

Strong Sell (90% confidence)

Last activity: 1 weeks ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$103.69M

Insider Roster (5 total, 5 active)

Insider Buys Sells Net Value Holdings
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
0 8 -$4.24M
740,188 shares
$21.50M
Collins Helen Louise
CHIEF MEDICAL OFFICER
0 5 -$3.92M
25,000 shares
$878K
Patel Anish
CHIEF OPERATING OFFICER
0 4 -$1.49M
215,254 shares
$6.02M
Heyman Richard A.
OTHER
0 6 -$413K
22,647 shares
$593K
Hohl Benjamin
CHIEF FINANCIAL OFFICER
0 1 -$296K
51,000 shares
$1.51M

Recent Transactions

SELL Collins Helen Louise (CHIEF MEDICAL OFFICER)

40,000 shares @ $35.10

$1.40M

Mar 25, 2026

Conviction: | View SEC Filing →
SELL Collins Helen Louise (CHIEF MEDICAL OFFICER)

5,000 shares @ $27.76

$139K

Mar 17, 2026

Conviction: | View SEC Filing →
SELL Collins Helen Louise (CHIEF MEDICAL OFFICER)

10,129 shares @ $30.19

$306K

Mar 10, 2026

Conviction: | View SEC Filing →
SELL Collins Helen Louise (CHIEF MEDICAL OFFICER)

29,871 shares @ $30.02

$897K

Mar 9, 2026

Conviction: | View SEC Filing →
SELL Hohl Benjamin (CHIEF FINANCIAL OFFICER)

10,000 shares @ $29.58

$296K

Mar 6, 2026

Conviction: | View SEC Filing →
SELL Collins Helen Louise (CHIEF MEDICAL OFFICER)

45,000 shares @ $26.17

$1.18M

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Heyman Richard A. (OTHER)

1,230 shares @ $26.18

$32K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER)

5,000 shares @ $29.04

$145K

Feb 6, 2026

Conviction: | View SEC Filing →
SELL Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER)

14,509 shares @ $26.90

$390K

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER)

5,491 shares @ $26.37

$145K

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Heyman Richard A. (OTHER)

718 shares @ $26.96

$19K

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Heyman Richard A. (OTHER)

512 shares @ $26.46

$14K

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER)

50,000 shares @ $29.13

$1.46M

Jan 9, 2026

Conviction: | View SEC Filing →
SELL Patel Anish (CHIEF OPERATING OFFICER)

48,057 shares @ $27.98

$1.34M

Jan 9, 2026

Conviction: | View SEC Filing →
SELL Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER)

41,198 shares @ $24.90

$1.03M

Jan 9, 2026

Conviction: | View SEC Filing →
SELL Heyman Richard A. (OTHER)

4,285 shares @ $25.00

$107K

Jan 9, 2026

Conviction: | View SEC Filing →
SELL Patel Anish (CHIEF OPERATING OFFICER)

243 shares @ $28.50

$7K

Jan 9, 2026

Conviction: | View SEC Filing →
SELL Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER)

33,802 shares @ $24.92

$842K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL Heyman Richard A. (OTHER)

8,015 shares @ $25.04

$201K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER)

7,500 shares @ $20.13

$151K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL Heyman Richard A. (OTHER)

1,620 shares @ $25.00

$41K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER)

5,000 shares @ $16.84

$84K

Dec 19, 2025

Conviction: | View SEC Filing →
SELL Patel Anish (CHIEF OPERATING OFFICER)

4,958 shares @ $20.76

$103K

Dec 8, 2025

Conviction: | View SEC Filing →
SELL Patel Anish (CHIEF OPERATING OFFICER)

1,705 shares @ $21.78

$37K

Dec 8, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.